Singapore to begin first human trial for potential Covid-19 treatment (TODAY)

Infectious diseases expert Ooi Eng Eong, who co-founded Tychan, the biotech company behind the treatment, told the media in a video conference that if trials prove successful, the drug could in future also be used to render temporary protection against infection by the coronavirus, as antibody drugs tend to be effective for about two to three weeks a dose.